SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases
SelectION has raised $5.4M in total funding. The most recent round was Series C. The last funding was announced in September 2025.
SelectION's investors include SDL Ventures, Global Source Ventures.
SelectION is headquartered in San Diego, United States.
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases
SelectION is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SelectION — Funding & Investors." VCBacked, September 15, 2025, https://www.vcbacked.co/company/selection. Accessed September 14, 2026.
VCBacked. (2025). SelectION — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/selection
{{cite web |title=SelectION — Funding & Investors |url=https://www.vcbacked.co/company/selection |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated